Proto Labs Inc

PRLB

Held by 1 specialist biotech fund

Share on X

Fund Holdings

Driehaus Capital

AI Signal

AI analyst context — unlock full analysis

Catalysts

No catalysts tracked.

Position Details

Driehaus CapitalNEWFeb 17, 2026

Shares: 382,155Value: $19.3M

**Signal Note: Driehaus Capital Position in Proto Labs (PRLB)** Proto Labs is a digital manufacturing platform for custom parts and PCBs, not a drug developer—this appears to be a misclassified filing or data error. Driehaus's $19.3M stake likely reflects conviction in PRLB's business model serving biotech/medtech supply chains, though the position size suggests modest portfolio conviction for a growth-focused manager. Without visibility into specific catalysts or valuation thesis, this entry warrants monitoring for quarterly commentary on manufacturing demand trends in life sciences.

More PRLB Analysis

Insider buy/sell details with names, titles, and amounts
AI-generated context for every signal

Start 7-Day Free Trial — $29/mo

Insider Signals

No insider signals tracked.

Also Held by These Funds

PTN1 fund WLDN1 fund LASR1 fund ONTO1 fund VALE1 fund TNDM1 fund TKO1 fund TNL1 fund

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Track specialist biotech funds, insider signals, and AI analysis

Start 7-Day Free Trial

Or get the free weekly brief: